SHP-2 enhances the survival and invasion of fibroblast-like synoviocytes (FLS) and the responsiveness to platelet-derived growth factor (PDGF) and tumor necrosis factor (TNF) in rheumatoid arthritis through the activation of focal adhesion kinase (FAK). The gene discussed is PTK2; the disease is rheumatoid arthritis.